Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K231218
    Date Cleared
    2024-01-19

    (266 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    AccuMedical Beijing Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Distal Access Catheter is indicated for the introduction of interventional devices into the peripheral and neurovasculature.

    Device Description

    The Distal Access Catheter is a single lumen, flexible, variable stiffness composite catheter which has a luer hub on the proximal end. The catheter shaft has a hydrophilic coating to reduce friction during use. The Distal Access Catheter has a radiopaque marker on the distal tip that is visible under fluoroscopy. The Distal Access Catheter inner lumen can accommodate guidewires up to 0.038 inches in diameter to aid in placement of the catheter system. The catheter has a straight tip. The catheter is offered in various lengths to accommodate physician preferences and anatomical variations. The catheter is provided sterile, nonpyrogenic, and is intended for single use only.

    AI/ML Overview

    The provided text describes information for a Distal Access Catheter, specifically related to its 510(k) premarket notification for FDA clearance. It details the device's characteristics, intended use, and comparisons to a predicate device, along with non-clinical performance testing (bench testing, biocompatibility, sterility, and shelf-life).

    However, the prompt asks for acceptance criteria and a study that proves a device meets acceptance criteria, with specific questions related to AI/Machine Learning (ML) performance, such as:

    1. A table of acceptance criteria and the reported device performance.
    2. Sample size used for the test set and data provenance.
    3. Number of experts used to establish ground truth and their qualifications.
    4. Adjudication method for the test set.
    5. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done and its effect size.
    6. If a standalone (algorithm only) performance study was done.
    7. The type of ground truth used.
    8. The sample size for the training set.
    9. How the ground truth for the training set was established.

    The provided FDA 510(k) document is for a physical medical device (catheter) and does NOT describe any AI/ML components or studies. Therefore, it does not contain the information necessary to answer the questions about AI/ML acceptance criteria, test sets, ground truth establishment, or clinical studies involving AI.

    Based on the provided document, here is a summary of acceptance criteria and performance for the physical device:

    Acceptance Criteria and Device Performance (for the physical catheter)

    1. A table of acceptance criteria and the reported device performance

    The document lists various non-clinical (bench) tests and biocompatibility tests. The "Result" column effectively indicates whether the device met the pre-defined acceptance criteria for each test.

    TestTest Method SummaryAcceptance Criteria (Implied by Result) & Reported Device Performance
    Bench Testing
    Dimensional VerificationMeasured effective length, inner diameter (proximal/distal), max outer diameter.Device met the dimensional specifications. (Implied acceptance: within specified dimensions)
    Visual InspectionInspected for structural or mechanical damage.Device met the visual specifications. (Implied acceptance: no structural/mechanical damage)
    Simulated Use and Compatibility TestingSimulated clinical use with compatible devices in a tortuous anatomical bench test model.Device performed as intended under simulated use conditions. (Implied acceptance: performed as expected)
    Delivery and RetrievalMeasured maximum forces to deliver and retrieve device through tortuous anatomical bench model.Device met the delivery and retrieval force specifications. (Implied acceptance: forces within specification)
    Tensile StrengthTested peak tensile force of all bonding points using a universal tensile machine per ISO 10555-1.Device met acceptance criteria determined with delivery and retrieval force testing. (Implied acceptance: passed)
    Torque StrengthDevices pre-conditioned and torqued to failure inside tortuous anatomical model with distal tip held fixed.Device torque strength is similar to the predicate. (Implied acceptance: comparable to predicate)
    Burst PressureEvaluated per ISO 10555-1:2013 following pre-conditioning.Device resistance to burst pressure is similar to the predicate. (Implied acceptance: comparable to predicate)
    Kink ResistanceDevices pre-conditioned and bonding points wrapped around varying size pin gauges until failure.Device kink resistance is similar to the predicate. (Implied acceptance: comparable to predicate)
    Coating IntegrityHydrophilic coating on catheter surface evaluated after particulate testing for defects.Device coating integrity is similar to the predicate. (Implied acceptance: comparable to predicate)
    Corrosion ResistanceEvaluated per ISO 10555-1:2013.Device met corrosion resistance specification. (Implied acceptance: passed)
    Air LeakageEvaluated per ISO 10555-1:2013 following pre-conditioning.Device integrity is suitable for intended clinical use and met requirements of ISO 10555-1. (Implied acceptance: passed)
    Liquid LeakageEvaluated per ISO 10555-1:2013 following pre-conditioning.Device integrity is suitable for intended clinical use and met requirements of ISO 10555-1. (Implied acceptance: passed)
    RadiopacityVisibility of distal marker band and catheter body evaluated under X-ray.Device radiopacity comparable to the predicate device. (Implied acceptance: comparable to predicate)
    Particulate TestingTest articles tracked multiple times through tortuous anatomical model with ancillary devices; particulates collected.Particulate generation of the subject device was comparable to the predicate device. (Implied acceptance: comparable to predicate)
    Luer Connector TestingEvaluated per ISO 80369-7 and ISO 80369-20.Device met the establish acceptance criteria. (Implied acceptance: passed)
    Tip Flexibility and Tip Buckling TestingCatheter distal tip evaluated following simulated use testing.Tip flexibility and tip buckling of the subject device are similar to the predicate device. (Implied acceptance: comparable to predicate)
    Biocompatibility
    CytotoxicityISO 10993-5:2009 MTT Method.The Distal Access Catheter, introducer sheath, and shaping mandrel were non-cytotoxic. (Implied acceptance: non-cytotoxic)
    Skin SensitizationISO 10993-10:2021 Guinea Pig Maximization Test.The Distal Access Catheter, introducer sheath, and shaping mandrel were non-sensitizers. (Implied acceptance: non-sensitizing)
    IrritationISO 10993-23:2021 Intracutaneous Reactivity Test.The Distal Access Catheter, introducer sheath, and shaping mandrel were non-irritant. (Implied acceptance: non-irritant)
    Acute Systemic ToxicityISO 10993-11:2017 Acute Systemic Toxicity Study in Mice.No mortality or evidence of acute systemic toxicity with the Distal Access Catheter, introducer sheath, and shaping mandrel test articles. (Implied acceptance: passed)
    Material-Mediated PyrogenicityUSP , ISO 10993-11:2017 Rabbit Pyrogen Study.The Distal Access Catheter, introducer sheath, and shaping mandrel were non-pyrogenic. (Implied acceptance: non-pyrogenic)
    Hemocompatibility (Hemolysis)ASTM F756-2017, ISO 10993-4:2017 ASTM Hemolysis Study (Direct and Indirect Contact).The Distal Access Catheter was non-hemolytic (direct and indirect contact). The introducer sheath and shaping mandrel were non-hemolytic (indirect contact). (Implied acceptance: non-hemolytic)
    Hemocompatibility (Complement Activation)ISO 10993-4:2017 Complement Activation, SC5b-9.The Distal Access Catheter results were similar to the negative control group. (Implied acceptance: no abnormal activation)
    Hemocompatibility (Partial ThromboplastinISO 10993-4:2017, ASTM F2382-2018 Partial Thromboplastin Time Study.The Distal Access Catheter results were similar to the negative control group. (Implied acceptance: no abnormal effect on clotting)
    Hemocompatibility (Thromboresistance)ISO 10993-4:2017 In Vivo Vein Thromboresistance Study.The Distal Access Catheter results were similar to the control and had no evidence of thrombosis. (Implied acceptance: no thrombosis)
    Genotoxicity (Bacterial Reverse Mutation)ISO 10993-3:2014 Bacterial Reverse Mutation Test.No backward mutation in Salmonella typhimurium with the Distal Access Catheter test article. (Implied acceptance: non-mutagenic)
    Genotoxicity (Mouse Lymphoma TK Assay)ISO 10993-3:2014 Mouse Lymphoma TK Assay.The Distal Access Catheter was non-mutagenic to mouse lymphoma cells (L5178Y TK+/--3.7.2C). (Implied acceptance: non-mutagenic)
    Genotoxicity (Chromosome Aberration Test)ISO 10993-3:2014 In vitro Mammalian Chromosome Aberration Test.The Distal Access Catheter results were similar to the negative control group. (Implied acceptance: no abnormal chromosomal aberration)
    SterilitySterilization process validated per ISO 11135:2014.Sterility Assurance Level (SAL) of 10^-4 achieved. EO and ECH residuals below ISO 10993-7:2008 limits. Bacterial Endotoxin Levels ).
    Shelf-lifeBaseline and accelerated shelf-life testing.Demonstrated the device will perform as intended to support the proposed 1-year shelf-life. (Implied acceptance: meets 1-year shelf-life stability)

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • The document describes bench testing and biocompatibility testing only. It does not mention any clinical data, patient data, retrospective, or prospective studies.
    • The sample sizes for these tests are not explicitly stated in numerical values (e.g., "n=X units were tested"), but implied by "test articles," "devices," or descriptions like "all bonding points."

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    • This question is irrelevant for the provided document as it concerns a physical catheter, not an AI/ML product requiring "ground truth" from experts interpreting medical images or data. The "ground truth" for this device's performance is established by objective engineering and biocompatibility test standards and measurements.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    • This question is irrelevant for the provided document as it concerns a physical catheter, not an AI/ML product requiring clinical adjudication of interpretations.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • No MRMC or any clinical effectiveness studies were performed or described. The document explicitly states: "No clinical studies were deemed necessary to demonstrate substantial equivalence."

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not applicable. This is a physical device, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    • For the physical device, the "ground truth" is defined by established engineering standards (e.g., ISO standards), physical measurements, chemical analyses, and biological assays. It's not based on expert clinical consensus or pathology in the context of diagnostic interpretation.

    8. The sample size for the training set

    • Not applicable. This is a physical device, not an AI/ML product that undergoes "training."

    9. How the ground truth for the training set was established

    • Not applicable. This is a physical device, not an AI/ML product.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1